HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engilbert Sigurdsson Selected Research

Agranulocytosis (Granulocytopenia)

12/2021HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.
12/2016Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Engilbert Sigurdsson Research Topics

Disease

14Schizophrenia (Dementia Praecox)
01/2024 - 10/2002
5Psychotic Disorders (Schizoaffective Disorder)
01/2024 - 01/2012
5Bipolar Disorder (Manic Depressive Psychosis)
01/2024 - 03/2011
4Treatment-Resistant Schizophrenia
12/2021 - 11/2013
2Genetic Risk Score
01/2024 - 01/2018
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2023 - 01/2020
2Agranulocytosis (Granulocytopenia)
12/2021 - 12/2016
2Neutropenia
12/2021 - 12/2016
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2024
1Mental Disorders (Mental Disorder)
11/2023
1Tachycardia (Tachyarrhythmias)
07/2023
1Infections
07/2023
1Treatment-Resistant Depressive Disorder
09/2022
1Synostosis
01/2022
1Neurodevelopmental Disorders
01/2022
1Microcephaly
01/2022
1Drug-Related Side Effects and Adverse Reactions
12/2021
1Constipation
10/2018
1Ileus
10/2018
1Type 2 Diabetes Mellitus (MODY)
10/2017
1Dyslipidemias (Dyslipidemia)
10/2017
1Substance-Related Disorders (Drug Abuse)
05/2015
1Vaccinia
10/2011
1Mediastinitis
10/2008
1Wound Infection (Wound Infections)
10/2008
1Wounds and Injuries (Trauma)
10/2008

Drug/Important Bio-Agent (IBA)

7Clozapine (Clozaril)FDA LinkGeneric
12/2021 - 10/2002
6Antipsychotic Agents (Antipsychotics)IBA
01/2024 - 10/2002
2Hallucinogens (Psychedelics)IBA
11/2023 - 09/2022
2Biomarkers (Surrogate Marker)IBA
07/2023 - 08/2009
2Methylphenidate (Ritalin)FDA LinkGeneric
07/2023 - 05/2015
2Transcription Factor 4IBA
10/2011 - 08/2009
2NeurograninIBA
10/2011 - 08/2009
2Neuregulin-1 (Neuregulin 1)IBA
02/2010 - 10/2002
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2010 - 09/2009
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2024
1Psilocybin (Psilocibin)IBA
09/2022
1Glutamate Receptors (Glutamate Receptor)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Sp4 Transcription FactorIBA
01/2022
1HLA-DQB1 antigen (HLA DQB1)IBA
12/2021
1FurinIBA
01/2021
1N-acetyltalosaminuronic acid (NAT)IBA
01/2021
1LaxativesIBA
10/2018
1NicotineFDA Link
01/2018
1Blood Glucose (Blood Sugar)IBA
10/2017
1Triglycerides (Triacylglycerol)IBA
10/2017
1LipidsIBA
10/2017
1IonsIBA
01/2012
1MetalsIBA
01/2012
1Phosphotransferases (Kinase)IBA
10/2011
1NeurocanIBA
03/2011
1CarbohydratesIBA
01/2011

Therapy/Procedure

1Therapeutics
05/2024
1Polypharmacy
01/2024
1Aftercare (After-Treatment)
01/2020
1Cognitive Training
01/2019
1Negative-Pressure Wound Therapy
10/2008